Board Strategy11 May 2022 15:38
The Hardide board has raised £9.4million of equity since 2017 (£2.5m in Oct 17, £3.6m in Feb 2019, £2.5m in Jan 2020, £0.8m in Feb 2021). This equity was all raised after the US factory was established in 2015. There is a familiar story to all the fund raises. Hardide needs funding for all the new capacity for all the exciting growth from aerospace, oil and gas etc. The shareholders have supported £9.4million of fund raises and there are 9 new furnaces of which 1 is large capacity and a new factory. This provides plenty of capacity for R&D, ~ £9million capacity for new business and ability to coat larger objects. I support the new factory investment but struggle with installing so much new reactor capacity so far in advance of contracted revenue. For example, Shareholders have taken massive dilution more than 5 years ago and Hardide has delivered 3% of aerospace revenue £8,400! Now the board are using the pretence of capacity restrictions for the new larger capacity reactor as a pre-cursor to yet more funding to support growth. I estimate revenue from Ansaldo in 1H 2022 was £226,000 ((£2.7 x 54% = £1,458k)- (£2.7m x 54%/1.49 = £978k x 1.26 = £1,232k)) based on disclosure in the interim results. If we assume the large capacity reactor can process £1.5m of revenue annually the reactor operated at approx 30% capacity in 1H 2022. Given the board has stated there is line of sight to positive cash flow and profitability can I suggest they do not do yet another highly dilutive equity raise. If Anasaldo want their blades coated, great, but surely it is not beyond the wit of the board to request i) prepayment ii) long term contract with sufficient covenant for asset backed financing to support the investment in new reactors. If the board of Hardide had delivered on the promised revenue growth historically I would be more supportive. Problem is they have not delivered the revenue. I would take much more confidence from asset backed financed being used to support the new reactor capacity because at least this way we can be confident the financier will have checked the revenue is contracted. It is call a win win allround - Ansaldo commit to revenue and get preferential commercial terms, Hardide gets the asset backed funding for growth, the shareholders do not have to suffer further dilution, and the Chairman is more popular.